Literature DB >> 14389736

Hepatic necrosis and other visceral lesions associated with phenylbutazone therapy.

J M MACCARTHY, R T JACKSON.   

Abstract

Entities:  

Keywords:  ANALGESICS/injurious effects; ARTHRITIS, RHEUMATOID/therapy; KIDNEYS/effect of drugs on; LIVER/effect of drugs on; NECROSIS

Mesh：

Substances：

Year:  1955        PMID： 14389736      PMCID： PMC1980417          DOI： 10.1136/bmj.2.4933.240

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  11 in total

1.  Phenylbutazone therapy; relation between the toxic and therapeutic effects and the blood level.

Authors:  E BRUCK; M E FEARNLEY; I MEANOCK; H PATLEY
Journal:  Lancet       Date:  1954-01-30       Impact factor: 79.321

2.  Death from hypersensitivity due to phenylbutazone.

Authors:  D J O'BRIEN; G STOREY
Journal:  Br Med J       Date:  1954-04-03

3.  Treatment of rheumatoid arthritis with phenylbutazone.

Authors:  D FREELAND; G STOREY; M THOMPSON
Journal:  Lancet       Date:  1953-06-20       Impact factor: 79.321

4.  Widespread serous membrane involvement by rheumatoid nodules.

Authors:  P ELLMAN; L CUDKOWICZ; J S ELWOOD
Journal:  J Clin Pathol       Date:  1954-08       Impact factor: 3.411

5.  Multiple visceral lesions due o phenylbutazone toxicity.

Authors:  J R NASSIM
Journal:  Br Med J       Date:  1954-10-30

6.  Phenylbutazone and renal function.

Authors:  B M JOHNSON; I M LARKIN
Journal:  Br Med J       Date:  1954-11-06

7.  Enhancing effect of cortisone on tuberculosis in the mouse.

Authors:  P D'ARCY HART; R J W REES
Journal:  Lancet       Date:  1950-09-23       Impact factor: 79.321

8.  The Pathology of Sulfonamide Allergy in Man.

Authors:  R H More; G C McMillan; G L Duff
Journal:  Am J Pathol       Date:  1946-07       Impact factor: 4.307

9.  Phenylbutazone (butazolidine) in the treatment of chronic arthritis.

Authors:  L CUDKOWICZ; J H JACOBS
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

10.  Agranulocytosis following phenylbutazone (butazolidin) therapy; report of a fatal case.

Authors:  C L STEINBERG; M G BOHROD; A I ROODENBURG
Journal:  J Am Med Assoc       Date:  1953-05-02
View more
  9 in total

1.  Fatal phenylbutazone hepatitis.

Authors:  J H FISHER
Journal:  Can Med Assoc J       Date:  1960-12-03       Impact factor: 8.262

2.  Megaloblastic anaemia induced by phenylbutazone.

Authors:  H N ROBSON; J R LAWRENCE
Journal:  Br Med J       Date:  1959-09-19

3.  An appraisal of phenylbutazone suppositories.

Authors:  C F HAWKINS; H T FAWNS
Journal:  Br Med J       Date:  1959-10-17

4.  [Mechanism of action of butazolidine].

Authors:  H GROS
Journal:  Klin Wochenschr       Date:  1956-05-01

5.  Phenylbutazone and Leukaemia.

Authors:  R H Bean
Journal:  Br Med J       Date:  1960-11-26

6.  Granulomas and cholestatic--hepatocellular injury associated with phenylbutazone. Report of two cases.

Authors:  K G Ishak; J P Kirchner; J K Dhar
Journal:  Am J Dig Dis       Date:  1977-07

7.  Iragapyrin toxicity.

Authors:  L Ramakumar; B G Goyal
Journal:  Indian J Pediatr       Date:  1967-02       Impact factor: 1.967

Review 8.  Effects of non-narcotic analgesics on the liver.

Authors:  L F Prescott
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  [Irgapyrine poisoning of a child with fatal outcome and special attention to changes in the electrocardiogram and toxicologic studies].

Authors:  K Ibe; K H Beyer; H Burmeister; K D Grosser
Journal:  Arch Toxikol       Date:  1967
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.